Literature DB >> 22101553

Anti-microtubule organizing center with microtubule by autoimmune target test is also useful serological marker in rheumatoid arthritis evaluation.

Duck-An Kim1, Think-You Kim.   

Abstract

Seropositivity of rheumatoid factor (RF) or anti-cyclic citrullinated peptide antibody (anti-CCP) is one domain of scoring system in new American College of Rheumatology/European League against Rheumatism classification criteria for rheumatoid arthritis (RA). We investigated usefulness of antiperinuclear factor (APF) and autoantibody to microtubule organizing center with microtubule (anti-MTOC-MT), which was detected by autoimmune target (AIT) test, as serological markers for the diagnosis of early RA. The test results of 3,503 patients from the outpatient clinic of The Hospital for Rheumatic Diseases who underwent test for RF, APF, anti-CCP and anti-MTOC-MT simultaneously for the work-up of RA were analyzed. Four kinds of tests showed same results only in 53.1% (1,861/3,503) of all subjects. The kappa coefficient between each test was distributed from -0.011 to 0.622. The agreement was best between RF and anti-CCP (kappa coefficient: 0.622), but the agreement was poor between anti-MTOC-MT and other 3 tests (kappa coefficient: 0.007 to -0.025). In both of RF- and anti-CCP-negative patients, the patients who showed positive result for APF were 4.6% (160/3,503) and for anti-MTOC-MT were 13.2% (464/3,503). RF and anti-CCP positivity could not include all of APF and anti-MTOC-MT positivity. Anti-MTOC-MT detected by AIT test was independent serological marker, and it might be also helpful for the diagnosis of early RA. Therefore, the combined detection of all four serologic markers can be useful for the evaluation of suspected RA patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22101553     DOI: 10.1007/s00296-011-2228-9

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  10 in total

1.  Should the external quality assessment sample of antinuclear antibodies be of a typical monospecific pattern?

Authors:  La-He Jearn; Think-You Kim
Journal:  Clin Chem Lab Med       Date:  2010-08       Impact factor: 3.694

2.  2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Authors:  Daniel Aletaha; Tuhina Neogi; Alan J Silman; Julia Funovits; David T Felson; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Tore K Kvien; Timothy Laing; Philip Mease; Henri A Ménard; Larry W Moreland; Raymond L Naden; Theodore Pincus; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

3.  Limitations of antinuclear antibody tests (HEp-2) are overcome with the autoimmune target test (IT-1) in systemic lupus erythematosus.

Authors:  La-He Jearn; Duck-An Kim; Think-You Kim
Journal:  J Rheumatol       Date:  2009-08       Impact factor: 4.666

4.  Antiperinuclear factor test is more useful than anti-Sa assay when used with anti-cyclic citrullinated peptide test in diagnosis of rheumatoid arthritis.

Authors:  Duck-An Kim; La-He Jearn; Think-You Kim
Journal:  J Rheumatol       Date:  2007-09       Impact factor: 4.666

5.  Sensitivity and specificity of 2010 rheumatoid arthritis classification criteria.

Authors:  Yuko Kaneko; Masataka Kuwana; Hideto Kameda; Tsutomu Takeuchi
Journal:  Rheumatology (Oxford)       Date:  2011-02-03       Impact factor: 7.580

6.  Is it necessary to combine detection of anticitrullinated protein antibodies in the diagnosis of rheumatoid arthritis?

Authors:  Jinxia Zhao; Xiangyuan Liu; Zhimin Wang; Rui Liu; Zhanguo Li
Journal:  J Rheumatol       Date:  2010-10-15       Impact factor: 4.666

7.  The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.

Authors:  Xia Liu; Rulin Jia; Jinxia Zhao; Zhanguo Li
Journal:  J Rheumatol       Date:  2009-05-15       Impact factor: 4.666

8.  Antikeratin antibody and antiperinuclear factor as markers for subclinical rheumatoid disease process.

Authors:  K Aho; R von Essen; P Kurki; T Palosuo; M Heliövaara
Journal:  J Rheumatol       Date:  1993-08       Impact factor: 4.666

9.  Rheumatoid factors antedating clinical rheumatoid arthritis.

Authors:  K Aho; M Heliövaara; J Maatela; T Tuomi; T Palosuo
Journal:  J Rheumatol       Date:  1991-09       Impact factor: 4.666

10.  Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors.

Authors:  Markus M J Nielen; Dirkjan van Schaardenburg; Henk W Reesink; Rob J van de Stadt; Irene E van der Horst-Bruinsma; Margret H M T de Koning; Moud R Habibuw; Jan P Vandenbroucke; Ben A C Dijkmans
Journal:  Arthritis Rheum       Date:  2004-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.